TY - JOUR
T1 - Identifying the most important confounders when assessing the association between low-grade systemic inflammation and musculoskeletal pain
T2 - A modified Delphi study
AU - Koop, Meghan A
AU - Lutke Schipholt, Ivo J
AU - Scholten-Peeters, Gwendolyne G M
AU - Coppieters, Michel W
N1 - © The Author(s) 2021. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.
PY - 2021/11
Y1 - 2021/11
N2 - OBJECTIVE: The association between low-grade systemic inflammation and musculoskeletal pain may be influenced by multiple factors. However, little is known about the relative importance of these factors, and few studies account for them. This Delphi study aimed to reach consensus on the most important confounders which influence the association between low-grade systemic inflammation and musculoskeletal pain.METHODS: The panel consisted of 48 experts. In Round 1, the experts proposed what they believed were important confounders. In Round 2, the experts indicated for each confounder whether they believed it was important (yes/no). At least 50% of experts had to indicate the confounder was important to be considered in the final round. In Round 3, the experts rated the importance of each confounder on a 7-point Likert scale. Consensus was reached if ≥ 75% of the experts considered the factor either extremely or moderately important.RESULTS: In Round 1, 120 confounders were proposed, which were synthesised into 38 distinct factors. In Round 2, 33 confounders met the criterion to be considered important. In Round 3, consensus was reached for 14 confounders: acute illness/trauma, immune disease, medication use, endocrine, nutritional, or metabolic disease, other musculoskeletal conditions, age, handling of blood samples, sex, cancer, body composition, pregnancy, cardiovascular disease, physical activity, and pain characteristics.CONCLUSIONS: These findings provide insight in the complexity of the association between low-grade systemic inflammation and musculoskeletal pain. Some factors currently listed as confounders may be re-classified as moderators or mediators as insights progress.
AB - OBJECTIVE: The association between low-grade systemic inflammation and musculoskeletal pain may be influenced by multiple factors. However, little is known about the relative importance of these factors, and few studies account for them. This Delphi study aimed to reach consensus on the most important confounders which influence the association between low-grade systemic inflammation and musculoskeletal pain.METHODS: The panel consisted of 48 experts. In Round 1, the experts proposed what they believed were important confounders. In Round 2, the experts indicated for each confounder whether they believed it was important (yes/no). At least 50% of experts had to indicate the confounder was important to be considered in the final round. In Round 3, the experts rated the importance of each confounder on a 7-point Likert scale. Consensus was reached if ≥ 75% of the experts considered the factor either extremely or moderately important.RESULTS: In Round 1, 120 confounders were proposed, which were synthesised into 38 distinct factors. In Round 2, 33 confounders met the criterion to be considered important. In Round 3, consensus was reached for 14 confounders: acute illness/trauma, immune disease, medication use, endocrine, nutritional, or metabolic disease, other musculoskeletal conditions, age, handling of blood samples, sex, cancer, body composition, pregnancy, cardiovascular disease, physical activity, and pain characteristics.CONCLUSIONS: These findings provide insight in the complexity of the association between low-grade systemic inflammation and musculoskeletal pain. Some factors currently listed as confounders may be re-classified as moderators or mediators as insights progress.
U2 - 10.1093/pm/pnab243
DO - 10.1093/pm/pnab243
M3 - Article
C2 - 34343332
SN - 1526-2375
VL - 22
SP - 2661
EP - 2669
JO - Pain medicine (Malden, Mass.)
JF - Pain medicine (Malden, Mass.)
IS - 11
ER -